Min-Seok Kwon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Min-Seok Kwon has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Taesung Park
Interdisciplinary Program in Bioinformatics, Seoul National University, Seoul, Republic of Korea
2 shared publications - Jin-Young Jang
Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea
1 shared publication - Junghyun Namkung
Immunodiagnostics R&D Team, IVD Business Unit, New Business Division, SK telecom Co., Seongnam, Korea
1 shared publication - Mee Joo Kang
Division of Cancer Registration and Surveillance, National Cancer Control Institute, National Cancer Center, Goyang, Republic of Korea
1 shared publication - Mira Park
Department of Preventive Medicine, Eulji University, Daejeon, Republic of Korea
1 shared publication - Sangjo Han
Immunodiagnostics R&D Team, IVD Business Unit, New Business Division, SK telecom Co., Seongnam, Korea
1 shared publication
Latest Publications
- Open Access
- 17 August 2015
- Published by Springer Nature in BMC Genomics
- Vol. 16 (S9) , S4
Integrative analysis of multi-omics data for identifying multi-markers for diagnosing pancreatic cancer
MicroRNA (miRNA) expression plays an influential role in cancer classification and malignancy, and miRNAs are feasible as alternative diagnostic markers for pancreatic cancer, a highly aggressive neoplasm with silent early symptoms, high metastatic potential, and resistance to conventional therapies. In this study, we evaluated the benefits of multi-omics data analysis by integrating miRNA and mRNA expression data in pancreatic cancer. Using support vector machine (SVM) modelling and leave-one-out cross validation (LOOCV), we evaluated the diagnostic performance of single- or multi-markers based on miRNA and mRNA expression profiles from 104 PDAC tissues and 17 benign pancreatic tissues. For selecting even more reliable and robust markers, we performed validation by independent datasets from the Gene Expression Omnibus (GEO) and the Cancer Genome Atlas (TCGA) data depositories. For validation, miRNA activity was estimated by miRNA-target gene interaction and mRNA expression datasets in pancreatic cancer. Using a comprehensive identification approach, we successfully identified 705 multi-markers having powerful diagnostic performance for PDAC. In addition, these marker candidates annotated with cancer pathways using gene ontology analysis. Our prediction models have strong potential for the diagnosis of pancreatic cancer.
- 17 August 2015
- Published by Springer Nature in BMC Genomics
- Vol. 16 (S9) , S4
Open AccessIntegrative analysis of multi-omics data for identifying multi-markers for diagnosing pancreatic cancer
MicroRNA (miRNA) expression plays an influential role in cancer classification and malignancy, and miRNAs are feasible as alternative diagnostic markers for pancreatic cancer, a highly aggressive neoplasm with silent early symptoms, high metastatic potential, and resistance to conventional therapies. In this study, we evaluated the benefits of multi-omics data analysis by integrating miRNA and mRNA expression data in pancreatic cancer. Using support vector machine (SVM) modelling and leave-one-out cross validation (LOOCV), we evaluated the diagnostic performance of single- or multi-markers based on miRNA and mRNA expression profiles from 104 PDAC tissues and 17 benign pancreatic tissues. For selecting even more reliable and robust markers, we performed validation by independent datasets from the Gene Expression Omnibus (GEO) and the Cancer Genome Atlas (TCGA) data depositories. For validation, miRNA activity was estimated by miRNA-target gene interaction and mRNA expression datasets in pancreatic cancer. Using a comprehensive identification approach, we successfully identified 705 multi-markers having powerful diagnostic performance for PDAC. In addition, these marker candidates annotated with cancer pathways using gene ontology analysis. Our prediction models have strong potential for the diagnosis of pancreatic cancer.
- Open Access
- 8 May 2014
- Published by Springer Nature in BMC Medical Genomics
- Vol. 7 (S1) , S6
IGENT: efficient entropy based algorithm for genome-wide gene-gene interaction analysis
With the development of high-throughput genotyping and sequencing technology, there are growing evidences of association with genetic variants and complex traits. In spite of thousands of genetic variants discovered, such genetic markers have been shown to explain only a very small proportion of the underlying genetic variance of complex traits. Gene-gene interaction (GGI) analysis is expected to unveil a large portion of unexplained heritability of complex traits.
- 8 May 2014
- Published by Springer Nature in BMC Medical Genomics
- Vol. 7 (S1) , S6
Open AccessIGENT: efficient entropy based algorithm for genome-wide gene-gene interaction analysis
With the development of high-throughput genotyping and sequencing technology, there are growing evidences of association with genetic variants and complex traits. In spite of thousands of genetic variants discovered, such genetic markers have been shown to explain only a very small proportion of the underlying genetic variance of complex traits. Gene-gene interaction (GGI) analysis is expected to unveil a large portion of unexplained heritability of complex traits.